ACM
SAGE icon

Aquatic Capital Management’s Sage Therapeutics SAGE Stock Holding History

Aquatic Capital Management’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-11,500
Closed -$216K – 1550
2024
Q1 		$216K Sell
11,500
-6,400
-36% -$148K 0.01% 744
2023
Q4 		$388K Buy
17,900
+9,800
+121% +$194K 0.01% 695
2023
Q3 		$167K Buy
8,100
+2,500
+45% +$72.2K 0.01% 720
2023
Q2 		$263K Buy
+5,600
New +$279K 0.01% 597
2022
Q4 		– Sell
-6,400
Closed -$251K – 1764
2022
Q3 		$251K Sell
6,400
-4,400
-41% -$170K 0.02% 560
2022
Q2 		$349K Buy
+10,800
New +$362K 0.11% 216
2022
Q1 		– Sell
-2,000
Closed -$85K – 1463
2021
Q4 		$85K Buy
+2,000
New +$83.7K 0.16% 163

Other funds holding SAGE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Aquatic Capital Management's SAGE Position: Q2 2024 in Review

Aquatic Capital Management sold out of Sage Therapeutics (SAGE) in Q2 2024, closing a stake of 11,500 shares — an estimated $216K sold.

Aquatic Capital Management first reported a position in SAGE in Q4 2021 and held it in 7 quarters. The position peaked at $388K in Q4 2023. 195 funds tracked by Wall St. Rank hold SAGE as of Q2 2024.

  • Aquatic Capital Management reported no remaining Sage Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Aquatic Capital Management sold 11,500 Sage Therapeutics shares in Q2 2024, an estimated $216K.
  • Aquatic Capital Management first reported a position in Sage Therapeutics in Q4 2021 and held it in 7 quarters.
  • Aquatic Capital Management's Sage Therapeutics position peaked at $388K in Q4 2023.
  • 195 funds tracked by Wall St. Rank held Sage Therapeutics as of Q2 2024.

Based on Aquatic Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.